Indegene Limited — Updates, 18-03-2025: Press Release

Indegene has been recognized among the Financial Times High-Growth Companies in Asia-Pacific for 2025, marking its second consecutive year in the ranking. This accolade highlights companies in the region achieving significant revenue growth, particularly through technology utilization and adaptive business models. Indegene, a digital-first life sciences commercialization company, attributes its growth to its healthcare expertise and contextualized technology, catering to major biopharma clients, emerging biotech firms, and medical device companies. The company employs approximately 5,000 people globally, with a robust presence in North America, Europe, and Asia across six operational hubs and 18 offices. This recognition underscores Indegene's strategic positioning and suggests a positive outlook for continued growth and market relevance in the life sciences sector.